TNF and depressive symptom measurement: Thus, we hypothesize that the upregulation of TNF-α levels in plasma and PBMCs of depression patients may result from a combined increase of miR-342, a TNF-α promoter, and downregulation of miR-155 and miR-146a, TNF-α negative regulators.